We are live on ! Find out more
Baxter Bros

Baxter Bros Portfolio holdings

AUM $889M Turnover 6.11%
1-Year Est. Return 15.41%
This Fund
S&P 500
This Quarter Est. Return
+8.47%
1 Year Est. Return
+15.41%
3 Year Est. Return
+84.05%
5 Year Est. Return
+98.31%
10 Year Est. Return
+348.76%
AUM
$417M
AUM Growth
+$44.7M
Cap. Flow
+$13.1M
Cap. Flow %
3.14%
Top 10 Hldgs %
42.4%
Holding
117
New
6
Increased
50
Reduced
41
Closed
6
Avg Time Held
3.7 years
Top 10 Avg Time Held
2.4 years
Top 20 Avg Time Held
2.7 years

Sector Composition

Rank Sector Weight
1 Financials 21.95%
2 Technology 21.32%
3 Industrials 15.62%
4 Communication Services 12.06%
5 Miscellaneous 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BRK.B icon
1
Berkshire Hathaway Class B
BRK.B
$1.26T
$29.4M 7.06%
137,442
+1,933
+1% +$397K
2013 Q2
21 quarters
MSFT icon
2
Microsoft
MSFT
$3.89T
$26.3M 6.32%
230,110
-2,789
-1% -$302K
2013 Q2
21 quarters
V icon
3
Visa
V
$794B
$22M 5.28%
146,674
-2,448
-2% -$348K
2013 Q2
21 quarters
INTU icon
4
Intuit
INTU
$91.3B
$20.8M 4.98%
91,317
+2,161
+2% +$464K
2013 Q2
21 quarters
GOOG icon
5
Alphabet (Google) Class C
GOOG
$3.6T
$16.8M 4.04%
280,980
+6,840
+2% +$410K
2013 Q2
21 quarters
UNP icon
6
Union Pacific
UNP
$180B
$15M 3.6%
92,086
+2,433
+3% +$366K
2013 Q2
21 quarters
CMCSA icon
7
Comcast
CMCSA
$89.3B
$12.4M 2.98%
350,417
+6,316
+2% +$224K
2013 Q2
21 quarters
DIS icon
8
Walt Disney
DIS
$205B
$11.7M 2.81%
99,989
+1,353
+1% +$151K
2013 Q2
21 quarters
INTC icon
9
Intel
INTC
$317B
$11.2M 2.68%
235,875
+15,304
+7% +$745K
2013 Q2
21 quarters
WFC icon
10
Wells Fargo
WFC
$258B
$10.5M 2.52%
199,440
-2,657
-1% -$152K
2013 Q2
21 quarters
BA icon
11
Boeing
BA
$136B
$9.8M 2.34%
26,232
+3,812
+17% +$1.34M
2013 Q4
19 quarters
ADP icon
12
Automatic Data Processing
ADP
$122B
$7.91M 1.9%
52,501
+3,832
+8% +$542K
2013 Q2
21 quarters
PAYX icon
13
Paychex
PAYX
$41.2B
$7.6M 1.82%
103,228
+1,103
+1% +$79.3K
2013 Q2
21 quarters
EW icon
14
Edwards Lifesciences
EW
$61.6B
$7.47M 1.79%
128,736
+600
+0.5% +$29.3K
2017 Q1
6 quarters
GS icon
15
Goldman Sachs
GS
$264B
$7.15M 1.72%
31,896
+6,143
+24% +$1.43M
2014 Q1
18 quarters
TMO icon
16
Thermo Fisher Scientific
TMO
$259B
$6.98M 1.68%
28,609
+3,995
+16% +$919K
2013 Q2
21 quarters
BNY icon
17
Bank of New York Mellon
BNY
$103B
$6.81M 1.64%
133,608
+22,280
+20% +$1.17M
2014 Q2
17 quarters
HON icon
18
Honeywell
HON
$70.6B
$6.8M 1.63%
45,257
+5,474
+14% +$776K
2013 Q2
21 quarters
TRP icon
19
TC Energy
TRP
$67.5B
$6.03M 1.45%
149,015
+185
+0.1% +$8.02K
2013 Q3
20 quarters
JNJ icon
20
Johnson & Johnson
JNJ
$688B
$5.4M 1.3%
39,110
-2,099
-5% -$279K
2013 Q2
21 quarters
PG icon
21
Procter & Gamble
PG
$394B
$5.19M 1.25%
62,394
-5,976
-9% -$489K
2013 Q2
21 quarters
MA icon
22
Mastercard
MA
$576B
$5.12M 1.23%
23,002
+280
+1% +$58.4K
2014 Q4
15 quarters
META icon
23
Meta Platforms (Facebook)
META
$1.64T
$5.02M 1.21%
30,531
+540
+2% +$97.8K
2015 Q4
11 quarters
UPS icon
24
United Parcel Service
UPS
$95.7B
$4.81M 1.15%
41,201
-50
-0.1% -$5.88K
2013 Q2
21 quarters
QCOM icon
25
Qualcomm
QCOM
$185B
$4.78M 1.15%
66,286
-232
-0.3% -$15.3K
2013 Q2
21 quarters

Similar funds

Baxter Bros's Q3 2018 Portfolio in Review

As of Q3 2018, Baxter Bros held 117 positions worth $417M, up 12% from $372M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Baxter Bros deployed $13.1M of net new capital in Q3 2018, opening 6 new positions and adding to 50 existing holdings. Its largest new stake was Bausch Health: 15,900 shares worth $408K.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was GE Aerospace, an estimated $835K trimmed.

  • Baxter Bros's largest Q3 2018 buy was Bausch Health: 15,900 shares worth $408K.
  • Baxter Bros added most to Texas Instruments in Q3 2018, an estimated $3.31M increase.
  • Baxter Bros's biggest Q3 2018 reduction was GE Aerospace, cutting an estimated $835K.
  • Baxter Bros fully exited VALEANT PHARMACEUTICALS INTL in Q3 2018, selling an estimated $370K.
  • Baxter Bros's ten largest holdings make up 42% of its $417M portfolio in Q3 2018.
  • Baxter Bros opened 6 new positions and closed 6 in Q3 2018.
  • Baxter Bros's portfolio value rose 12% quarter-over-quarter to $417M.

Based on Baxter Bros's 13F filing for Q3 2018, filed 11 Oct 2018.